Zoetis Equine Offers Core EQ Innovator® Vaccines to Horses Adopted from ASPCA Right Horse Partners During Adopt a Horse Month

Syringes representing core horse vaccinations.
Syringes representing core horse vaccinations. Fabio Berti

Newsdate: Wednesday, May 15, 2024 - 10:30 am
Location: PARSIPPANY, New Jersey

The ASPCA® (The American Society for the Prevention of Cruelty to Animals®) has announced that Zoetis Equine has, for the fifth consecutive year, generously donated 1,500 doses of Core EQ Innovator® vaccine  to ASPCA Right Horse™ Adoption Partners and the horses in their care. The donation coincides with Adopt a Horse Month, a nationwide campaign established by the ASPCA in 2021 to help more equines find great homes.

Veterinarian vaccinating a horse with help of intern.

Veterinarian vaccinating a horse with help of intern.

Adoption Partners of the ASPCA Right Horse program nationwide will receive free Core EQ Innovator® vaccines for the horses in their care.
© 2013 by Karin Belgrave

“Our ongoing partnership with Zoetis is just one exciting example of how the equine industry is committed to supporting equine adoption and helping horses in transition through all phases of their journey,” said Christie Schulte Kappert, senior director of ASPCA Equine Welfare. “We are grateful to Zoetis for their generous donations as they directly assist equine organizations in their efforts to save more horses’ lives while they work tirelessly to promote equine adoption not only during Adopt a Horse Month, but year-round.”

Throughout the country, Adoption Partners of the ASPCA Right Horse program care for equines of varying breeds, ages and backgrounds as they transition from one home or career to the next. All horses face ongoing exposure to the five potentially fatal “core” equine diseases–rabies, tetanus, West Nile virus and Eastern and Western equine encephalomyelitis.

1,500 horses who have been adopted from ASPCA Right Horse partner organizations will be vaccinated by a veterinarian with Core EQ Innovator, the first and only vaccine to help protect horses against all five core diseases in one injection.

“We’re extremely grateful for partners like the ASPCA who work tirelessly to make the world a better place for horses and other animals, a mission we wholeheartedly support,” said Nathan Voris, DVM, MBA, Associate Director, Equine Technical Services with Zoetis.

“At Zoetis Equine, a division of the world’s leading animal health company, we work day in and day out to protect horses with solutions like the Core EQ Innovator vaccine. We’re very proud to support ASPCA’s efforts to find new homes for horses in need and look forward to our continued partnership.”

The ASPCA Right Horse program hosts a collective of industry professionals, including Zoetis, as well as equine welfare organizations and advocates, working together to reframe the conversation around equine adoption and improve the lives of horses in transition through a dialogue of kindness and respect. In collaboration with over 100 industry and adoption partners, the program is focused on shattering the stigma surrounding horses in transition to increase adoption.

Through Adopt a Horse Month, the ASPCA strives to raise public enthusiasm and commitments to horse adoption to the high levels traditionally seen in dog and cat adoption. The ASPCA and Zoetis encourage the public to support their local animal welfare organizations by adopting, volunteering their time, donating supplies, or becoming foster caregivers. To find an organization to support, please visit myrighthorse.org. For more information about the ASPCA’s efforts to help horses, please visit aspca.org.

About the ASPCA®
Founded in 1866, the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) was the first animal welfare organization to be established in North America and today serves as the nation’s leading voice for vulnerable and victimized animals. As a 501(c)(3) not-for-profit corporation with more than two million supporters nationwide, the ASPCA is committed to preventing cruelty to dogs, cats, equines, and farm animals throughout the United States. The ASPCA assists animals in need through on-the-ground disaster and cruelty interventions, behavioral rehabilitation, animal placement, legal and legislative advocacy, and the advancement of the sheltering and veterinary community through research, training, and resources. For more information, visit www.aspca.org and follow the ASPCA on Facebook, X, Instagram and TikTok.

About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide—from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit zoetis.com.

The Zoetis Equine division is committed to providing horse care you can count on. Our team includes numerous equine veterinarians and other experts who are inspired daily by the opportunity and profound responsibility to support horses, the owners who love them, and the equine veterinarians and other care team members who safeguard their well-being. Whether at the clinic or in the field, Zoetis is always by your side with a comprehensive, innovative portfolio of equine products and services at every step of a horse’s care and throughout the journey of a horse’s life. Visit zoetisequine.com to learn more.

Press release by Hannah Skallman - Zoetis Equine

About the Author

Press Release

Author picture

This news article is a press release received by the organization or person noted above. Press releases from recognized horse health companies and individuals are frequently posted on EquiMed as a service to our visitors. Please contact the author of the press release directly for additional information.